Vermersch, M.; Mulé, S.; Chalaye, J.; Galletto Pregliasco, A.; Emsen, B.; Amaddeo, G.; Monnet, A.; Stemmer, A.; Baranes, L.; Laurent, A.;
et al. Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients. J. Clin. Med. 2021, 10, 4017.
https://doi.org/10.3390/jcm10174017
AMA Style
Vermersch M, Mulé S, Chalaye J, Galletto Pregliasco A, Emsen B, Amaddeo G, Monnet A, Stemmer A, Baranes L, Laurent A,
et al. Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients. Journal of Clinical Medicine. 2021; 10(17):4017.
https://doi.org/10.3390/jcm10174017
Chicago/Turabian Style
Vermersch, Mathilde, Sébastien Mulé, Julia Chalaye, Athena Galletto Pregliasco, Berivan Emsen, Giuliana Amaddeo, Aurélien Monnet, Alto Stemmer, Laurence Baranes, Alexis Laurent,
and et al. 2021. "Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients" Journal of Clinical Medicine 10, no. 17: 4017.
https://doi.org/10.3390/jcm10174017
APA Style
Vermersch, M., Mulé, S., Chalaye, J., Galletto Pregliasco, A., Emsen, B., Amaddeo, G., Monnet, A., Stemmer, A., Baranes, L., Laurent, A., Leroy, V., Itti, E., & Luciani, A.
(2021). Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients. Journal of Clinical Medicine, 10(17), 4017.
https://doi.org/10.3390/jcm10174017
